Research Article
Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19
Table 1
Detection results of lymphocyte subsets in two-week postrecovery patients and HCs (cases, %).
| | Groups | Total lymphocyte | CD3+ T cell | CD3+CD4+ T cell | CD3+CD8+ T cell | CD19+ B cell | CD56+ NK cell | CD4+/CD8+ | | RP | HCs | RP | HCs | RP | HCs | RP | HCs | RP | HCs | RP | HCs | RP | HCs |
| | Below normal values (, %) | 22 (66.67) | 5 (17.86) | 18 (54.55) | 5 (17.86) | 18 (54.55) | 5 (17.86) | 27 (81.82) | 4 (14.29) | 23 (69.70) | 15 (53.57) | 17 (51.52) | 7 (25.00) | 0 (0) | 0 (0) | | Within normal values (, %) | 9 (27.27) | 18 (64.28) | 12 (36.36) | 19 (67.86) | 13 (39.39) | 23 (82.14) | 5 (15.15) | 17 (60.71) | 9 (27.27) | 12 (42.86) | 16 (48.48) | 17 (60.71) | 29 (87.88) | 27 (96.43) | | Above normal values (, %) | 2 (6.06) | 5 (17.86) | 3 (9.09) | 4 (14.28) | 2 (6.06) | 0 (0) | 1 (3.03) | 7 (25.00) | 1 (3.03) | 1 (3.57) | 0 (0) | 4 (14.29) | 4 (12.12) | 1 (3.57) |
|
|
RP: two-week postrecovery patients; HCs: healthy controls.
|
